Illinois college of pharmacy petitions FDA to remove clinical requirements for biosimilars
The University of Illinois Chicago’s College of Pharmacy last week petitioned the FDA to remove clinical efficacy testing for all new biosimilars — and not just …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.